Table 2.

Correlates of hepatic and peripheral insulin sensitivity

Variable	% Suppression of EGP		Rd-low		M/I-low		M/I-high
	White	Black	White	Black	White	Black	White	Black
Body composition
Body fat (kg)	0.08	–0.64*	–0.09	–0.34	0.01	–0.64*	0.12	–0.60*
Waist	0.09	–0.65**	–0.18	–0.73**	–0.25	–0.67**	–0.44	–0.73*
VAT	–0.04	–0.52*	–0.20	–0.35	–0.34	–0.62*	–0.62*	–0.30
SAT	0.19	–0.54*	–0.21	–0.26	0.13	–0.45	0.17	–0.50*
Ectopic fat
Liver fat	0.28	–0.57*	–0.44	–0.41	–0.45	–0.34	–0.53	–0.21
Soleus IMCL	0.59*	–0.46	–0.16	–0.52	0.12	–0.62*	–0.08	–0.46
Soleus fat (%)	0.34	–0.56*	–0.04	–0.40	0.27	–0.66*	0.09	–0.33
Muscle gene expression
IRS	–0.32	0.49	0.04	0.65*	–0.15	0.56*	–0.37	0.66*
VAMP	–0.37	0.43	–0.07	0.68**	–0.18	0.52	–0.49	0.64*
SCD1	–0.33	0.49	–0.03	0.90**	–0.23	0.53	–0.29	0.72**
Circulating adipokines
Adiponectin	0.41	0.49	0.47	0.77**	0.64**	0.56*	0.75**	0.71**

Values are Pearson correlation coefficients

^*p<0.05

^**p<0.01

M/I-high, M/I corrected for circulating insulin levels during the high-dose (40 mU m^–2 min^–1) clamp; M/I-low, M/I corrected for circulating insulin levels during the low-dose clamp; Rd-low, Rd during the low-dose (10 mU m^–2 min^–1 )clamp